Although IKZF1 deletions are an important clinical prognostic factor we were unable to identify a unique IKZF1 associated protein expression signature in pediatric Ph− BCP-ALL and consequently no specific targets for future therapy of Ph−IKZF1 deleted BCP-ALL were identified. This evidence concerns the gene OPN1SW and acute lymphoblastic leukemia.